Home » Clinical Trials » Medical Areas
Therapeutic Areas: Pediatrics/Neonatology | Pulmonary/Respiratory Diseases
Disease Category: Asthma (Pediatric)

Trial Information

Asthma Study CIGE025BUS26

Novartis is conducting this clinical study is to determine how moderate to severe allergic asthma affects the parents and children between the ages of 6 and 11 years old. The study will assess the child's quality of life, growth, missed days of school, number of medicines required, and number of visits to the doctor's office required to treat their asthma. The study will also assess how asthma affects their parent's quality of life and days of work missed due to the child's asthma. Participating children must be diagnosed with moderate to severe allergic asthma which is not well controlled. This study does not require participating children to take any new medicines or treatments for asthma.

Participating children and their parent or caregiver will be required to visit the study doctor's office every 6 months and answer questions at home over the phone monthly, or on paper every 3 months over a 12-24 month period.
For more information about this clinical trial, visit www.NovartisClinicalTrials.com

Research Center
Located In:
Various Cities OK

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.